Lista de obras -

Adenoviral E4orf3 and E4orf6 proteins, but not E1B55K, increase killing of cancer cells by radiotherapy in vivo

artículo científico publicado en 2010

Analysis of predictive and prognostic factors in 290 patients treated with oncolytic adenoviruses.

artículo científico publicado en 2015

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

artículo científico publicado en 2013

Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors

artículo científico publicado en 2014

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

artículo científico publicado en 2015

Fate of fenestration in children treated with fontan operation

artículo científico publicado en 2015

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

artículo científico publicado en 2013

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy ⬇️

artículo científico publicado en 2015

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus

artículo científico publicado en 2011

Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients

artículo científico publicado en 2018

Light to our people: Educational organization and the mobilization of fennomania in the 1870s

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures

artículo científico publicado en 2009

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

artículo científico publicado en 2018

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

artículo científico publicado en 2016

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

artículo científico publicado en 2013

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

artículo científico publicado en 2015

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

artículo científico publicado en 2016

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

artículo científico publicado en 2014

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

artículo científico publicado en 2015

T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.

artículo científico publicado en 2015

Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

artículo científico publicado en 2010

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

artículo científico publicado en 2015

Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer

artículo científico publicado en 2011

Lista de obras de

Adenoviral E4orf3 and E4orf6 proteins, but not E1B55K, increase killing of cancer cells by radiotherapy in vivo

Analysis of predictive and prognostic factors in 290 patients treated with oncolytic adenoviruses.

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Fate of fenestration in children treated with fontan operation

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy ⬇️

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus

Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients

Light to our people: Educational organization and the mobilization of fennomania in the 1870s

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.

Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer